Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,648
Sort by:

Poliomyelitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major poliomyelitis markets are expected to exhibit a CAGR of 5.04% during 2024-2034. The poliomyelitis market has been comprehensively analyzed in IMARC's new report titled 'Poliomyelitis Marke...

May 2024 133 pages

Pollen Allergy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pollen allergy markets are expected to exhibit a CAGR of 2.79% during 2024-2034. The pollen allergy market has been comprehensively analyzed in IMARC's new report titled 'Pollen Allergy Ma...

May 2024 132 pages

Polycystic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major polycystic kidney disease markets reached a value of US$ 358.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 622.1 Million by 2034, exhibiting a growth rate (C...

May 2024 134 pages

Polycystic Ovarian Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major polycystic ovarian syndrome markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 128 pages

Polycythemia Vera Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major polycythemia vera markets reached a value of US$ 17.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 68.5 Billion by 2034, exhibiting a growth rate (CAGR) of 13...

May 2024 133 pages

Polymyalgia Rheumatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major polymyalgia rheumatica markets reached a value of US$ 3,287.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12,677.8 Million by 2034, exhibiting a growth rate...

May 2024 131 pages

Polymyositis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major polymyositis markets are expected to exhibit a CAGR of 3.52% during 2024-2034. The polymyositis market has been comprehensively analyzed in IMARC's new report titled 'Polymyositis Market:...

May 2024 134 pages

Porphyria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major porphyria markets reached a value of US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.6 Billion by 2034, exhibiting a growth rate (CAGR) of 4.8% during...

May 2024 137 pages

Post-Bariatric Hypoglycemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major post-bariatric hypoglycemia markets are expected to exhibit a CAGR of 5.28% during 2024-2034. The post-bariatric hypoglycemia market has been comprehensively analyzed in IMARC's new report...

May 2024 140 pages

Post Menopausal Osteoporosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major post menopausal osteoporosis markets reached a value of US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.0 Billion by 2034, exhibiting a growth rate (CA...

May 2024 138 pages

Post-Partum Depression Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major post-partum depression markets reached a value of US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 50.2 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 139 pages

Post-Traumatic Stress Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major post-traumatic stress disorder markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (...

May 2024 132 pages

Postmenopausal Vaginal Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major postmenopausal vaginal atrophy markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (...

May 2024 137 pages

Postoperative Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major postoperative pain markets reached a value of US$ 2,615.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,456.0 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 128 pages

Pouchitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pouchitis markets reached a value of US$ 51.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 117.6 Million by 2034, exhibiting a growth rate (CAGR) of 7.73% dur...

May 2024 137 pages

Prader-Willi Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Prader-Willi syndrome markets are expected to exhibit a CAGR of 3.65% during 2024-2034. The Prader-Willi syndrome market has been comprehensively analyzed in IMARC's new report titled 'Pra...

May 2024 133 pages

Precocious Puberty Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major precocious puberty markets are expected to exhibit a CAGR of 6.19% during 2024-2034. The precocious puberty market has been comprehensively analyzed in IMARC's new report titled 'Precociou...

May 2024 136 pages

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major prediabetes markets reached a value of US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 48.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.72% du...

May 2024 130 pages

Preeclampsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major preeclampsia markets reached a value of US$ 712.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 856.5 Million by 2034, exhibiting a growth rate (CAGR) of 1.69%...

May 2024 133 pages

Premature Ejaculation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major premature ejaculation markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 134 pages

Presbyopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major presbyopia markets are expected to exhibit a CAGR of 3.29% during 2024-2034. The presbyopia market has been comprehensively analyzed in IMARC's new report titled 'Presbyopia Market: Epidem...

May 2024 130 pages

Primary Biliary Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary biliary cholangitis markets reached a value of US$ 510 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,200 Million by 2034, exhibiting a growth rate (C...

May 2024 136 pages

Primary Gastric Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary gastric lymphoma markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.1 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Primary Immune Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary immune deficiency markets reached a value of US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.4 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 135 pages

Primary Myelofibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary myelofibrosis markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The primary myelofibrosis market has been comprehensively analyzed in IMARC's new report titled 'Pri...

May 2024 140 pages

Primary Sclerosing Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary sclerosing cholangitis markets are expected to exhibit a CAGR of 5.84% during 2024-2034. The primary sclerosing cholangitis market has been comprehensively analyzed in IMARC's new...

May 2024 137 pages

Prinzmetal Angina Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Prinzmetal angina markets are expected to exhibit a CAGR of 3.8% during 2024-2034. The Prinzmetal angina market has been comprehensively analyzed in IMARC's new report titled 'Prinzmetal A...

May 2024 133 pages

Progressive Familial Intrahepatic Cholestasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major progressive familial intrahepatic cholestasis markets are expected to exhibit a CAGR of 4.68% during 2024-2034. The progressive familial intrahepatic cholestasis market has been comprehens...

May 2024 140 pages

Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The progressive pulmonary fibrosis (PPF) market has been comprehensively analyzed in IMARC's new report titled 'Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size,...

May 2024 134 pages

Proliferative Vitreoretinopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major proliferative vitreoretinopathy markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.1 Billion by 2034, exhibiting a growth rate...

May 2024 139 pages

Propionic Acidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major propionic acidemia markets are expected to exhibit a CAGR of 2.74% during 2024-2034. The propionic acidemia market has been comprehensively analyzed in IMARC's new report titled 'Propionic...

May 2024 137 pages

Proteinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major proteinuria markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.14% duri...

May 2024 129 pages

Proteus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The proteus syndrome market reached a value of US$ 1.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.8 Billion by 2034,...

May 2024 132 pages

Prurigo Nodularis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major prurigo nodularis markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The prurigo nodularis market has been comprehensively analyzed in IMARC's new report titled 'Prurigo Nod...

May 2024 140 pages

Pruritus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pruritus markets reached a value of US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.8 Billion by 2034, exhibiting a growth rate (CAGR) of 2.42% during...

May 2024 137 pages

Pseudoxanthoma Elasticum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pseudoxanthoma elasticum markets are expected to exhibit a CAGR of 1.21% during 2024-2034. The pseudoxanthoma elasticum market has been comprehensively analyzed in IMARC's new report title...

May 2024 135 pages

Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The psoriasis market reached a value of US$ 19.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 35.8 Billion by...

May 2024 133 pages

Psychomotor Agitation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major psychomotor agitation markets are expected to exhibit a CAGR of 1.92% during 2024-2034. The psychomotor agitation market has been comprehensively analyzed in IMARC's new report titled 'Psy...

May 2024 136 pages

Psychosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major psychosis markets reached a value of US$ 10.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.68% duri...

May 2024 138 pages

Ptosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ptosis markets reached a value of US$ 770.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,306.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.92% dur...

May 2024 136 pages

Pulmonary Embolism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary embolism markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 5.5...

May 2024 136 pages

Pulmonary Hypertension Associated with Interstitial Lung Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary hypertension associated with interstitial lung disease markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion b...

May 2024 134 pages

Pulmonary Sarcoidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary sarcoidosis markets reached a value of US$ 17.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 53.3 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 128 pages

Pyoderma Gangrenosum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pyoderma gangrenosum markets reached a value of US$ 126.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 185.1 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Pyruvate Kinase Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pyruvate kinase deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The pyruvate kinase deficiency market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Raynaud's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Raynaud's disease markets are expected to exhibit a CAGR of 7.68% during 2024-2034. The Raynaud's disease market has been comprehensively analyzed in IMARC's new report titled 'Raynaud's D...

May 2024 131 pages

Recurrent Glioblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent glioblastoma markets are expected to exhibit a CAGR of 5.85% during 2024-2034. The recurrent glioblastoma market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Recurrent Head and Neck Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent head and neck squamous cell carcinoma markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.5 Billion by 2034, exhibitin...

May 2024 128 pages

Recurrent Malignant Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent malignant glioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 130 pages

Recurrent Pericarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent pericarditis markets are expected to exhibit a CAGR of 4.08% during 2024-2034. The recurrent pericarditis market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 134 pages

Filters

Search

Categories

790
26
203
153
137
134
125
90
65,573
803
720
771
123

Publishers

179
1
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
370
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
239
536
361
1
1,357
60
1,696
8
8,921
2,215
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
297
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
787
495
2
2
2
117
191
102
53
23
700
26
133
522
174
622
64,679

Price

Date

Pages

Offers

1
280
1
1